Oma Fertility vs Revvity
Side-by-side comparison of AI visibility scores, market position, and capabilities
Oma Fertility operates affordable mini IVF clinics using a lower-stimulation protocol that reduces medication costs and side effects, making IVF accessible to more patients.
About
Oma Fertility is a fertility clinic company founded in 2019 that operates a network of fertility clinics using minimal stimulation IVF (mini IVF) as a primary treatment approach, offering IVF at significantly lower cost than conventional high-stimulation protocols. Mini IVF uses fewer and lower doses of fertility medications, reducing medication costs from $3,000-5,000 to a fraction of that amount while also decreasing the risk of ovarian hyperstimulation syndrome. Oma pairs this lower-cost clinical model with efficient clinic operations, transparent pricing, and subscription plans that make ongoing IVF cycles economically sustainable for patients who might otherwise not afford conventional IVF. The company has raised $40M and operates multiple clinic locations primarily in the Midwest and Southeast United States, targeting the large population of fertility patients who are priced out of conventional IVF at $20,000+ per cycle. Oma Fertility has positioned itself in the value segment of the fertility clinic market, complementing premium networks like Kindbody by serving cost-conscious patients who prioritize affordability and accessibility over premium clinic amenities.
Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.
About
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.